India's most comprehensive portal on pharmaceutical News, …
WEB4 days ago · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
WHO and partners to call for urgent, high-level action to address ...
WEB20 hours ago · The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges, and invest in global public health, at meetings throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79), to be held in New York from 20 ...
Roche announces phase III CENTERSTONE study of Xofluza …
WEB1 day ago · Roche announced positive topline results of the phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral, showing a reduction in the transmission of influenza viruses. The study met its primary endpoint, demonstrating that a single, oral dose of Xofluza taken by people infected with ...
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 ...
WEB1 day ago · InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid ...
About Pharmabiz
WEBPharmabiz.com is a comprehensive portal on the Indian pharmaceuticals industry, promoted by Saffron Media Pvt. Ltd. in Mumbai. This portal has a dedicated team of senior journalists, marketing professionals and key industry representatives. The team is headed by Mr P A Francis, who has been tracking the pharmaceutical industry for more than 29 ...
About Us - Pharmabiz.com
WEBMr. Sanjiv D Kaul, is currently the management advisor to ChrysCapital,a leading international consulting firm based in New Delhi.He is the former vice-president and head of corporate affairs, Ranbaxy Laboratories Limited and has been the key driver for Ranbaxy's aggressive internationalisation drive in markets as varied as Africa, Commonwealth of Independent States, Asia - Pacific and China ...
EU drug regulator approves use of Bavarian Nordic's mpox vaccine ...
WEB22 hours ago · MVA-BN is approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA. This is the second EMA approval of an MVA-BN-based vaccine for a younger population. The decision comes after one week the WHO approved the vaccine for adults. The CHMP recommendation follows the submission last month to EMA ...
Acelyrin to present positive results from global phase 3 trial of ...
WEB14 hours ago · Acelyrin, Inc., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, announced that positive results from the company’s global phase 3 clinical trial of izokibep in moderate-to-severe hidradenitis suppurativa (HS ...
PharmaBiz
WEBThe sections included in Pharmabiz Services are: You could also subscribe to ePharmail, the daily electronic newsletter from Pharmabiz or a special combined package offer for Pharmabiz Services + ePharmail is available at a discounted rate. For subscription details please or drop us an email on.
FDI inflow into hospitals & diagnostic centres grows close to three ...
WEB1 day ago · The growth of FDI inflow was one of the lowest for the segment during the fiscal year 2023-24 in the last three fiscal years, with the year 2022-23 reporting a growth of around 91 per cent, and almost three fold growth in the year before that, at $208.05 million FDI inflow in 2021-22. The cumulative FDI infusion into the sector from April, 2000 ...